XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.2
REVENUE
9 Months Ended
Sep. 30, 2021
REVENUE [Abstract]  
REVENUE
NOTE 3 — REVENUE:

Disaggregation of Revenue

The following table disaggregates total revenues:

   
For the three months ended
 
 
September 30, 2021
   
September 30, 2020
 
   
Exchange
Transactions
   
Non-Exchange
Transactions
   
Total
   
Exchange
Transactions
   
Non-Exchange
Transactions
   
Total
 
Net product sales
 
$
9,371,160
   
$
-
   
$
9,371,160
   
$
8,406,457
   
$
-
   
$
8,406,457
 
R&D revenue
   
441
     
-
     
441
     
1,444,724
     
-
     
1,444,724
 
Government grant income
   
-
     
2,400,000
     
2,400,000
     
-
     
209,776
     
209,776
 
License and royalty revenue
   
286,843
     
-
     
286,843
     
211,521
     
-
     
211,521
 
   
$
9,658,444
   
$
2,400,000
   
$
12,058,444
   
$
10,062,702
   
$
209,776
   
$
10,272,478
 

   
For the nine months ended
 
 
September 30, 2021
   
September 30, 2020
 
   
Exchange
Transactions
   
Non-Exchange
Transactions
   
Total
   
Exchange
Transactions
   
Non-Exchange
Transactions
   
Total
 
Net product sales
 
$
17,327,204
   
$
-
   
$
17,327,204
   
$
17,914,623
   
$
-
   
$
17,914,623
 
R&D revenue
   
1,107,808
     
-
     
1,107,808
     
3,546,385
     
-
     
3,546,385
 
Government grant income
   
-
     
8,030,000
     
8,030,000
      -
     
209,776
     
209,776
 
License and royalty revenue
   
779,901
     
-
     
779,901
     
572,450
     
-
     
572,450
 
   
$
19,214,913
   
$
8,030,000
   
$
27,244,913
   
$
22,033,458
   
$
209,776
   
$
22,243,234
 

Exchange transactions are recognized in accordance with ASC Topic 606, Revenue from Contracts with Customers, while non-exchange transactions are recognized in accordance with ASU 2018-08, Not-For-Profit Entities (Topic 958): Clarifying the Scope and Accounting Guidance for Contributions Received and Contributions Made.

During the three and nine months ended September 30, 2021, the Company recognized government grant income totaling $2.4 million and $8.0 million, which was awarded under a contract the Company entered into with BARDA on December 2, 2020.

The following table disaggregates total revenues by geographic location:

 
For the three months ended
   
For the nine months ended
 
   
September 30,
2021
   
September 30,
2020
   
September 30,
2021
   
September 30,
2020
 
Africa
 
$
1,293,405
   
$
1,874,518
   
$
4,104,619
   
$
3,310,603
 
Asia
   
208,750
     
168,052
     
479,297
     
650,659
 
Europe & Middle East
   
1,132,961
     
2,887,209
     
4,539,444
     
6,698,382
 
Latin America
   
5,698,920
     
4,618,560
     
6,444,456
     
7,515,523
 
United States
   
3,724,408
     
724,139
     
11,677,097
     
4,068,067
 
   
$
12,058,444
   
$
10,272,478
   
$
27,244,913
   
$
22,243,234
 

Contract Liabilities

Deferred revenue relates to payments received in advance of performance under the contract. Deferred revenue is recognized as revenue as (or when) the Company performs under the contract. At June 30, 2021, the Company reported $0.4 million in deferred revenue, substantially all of which was earned and recognized during the three months ended September 30, 2021, with the remaining amount expected to be recognized in the three months ending December 31, 2021.